Joseph Munyi, a Kenyan citizen, has been living with HIV for 8 years and, much like other HIV patients, is unemployed. He has been receiving his medication free of charge on account of government programmes and outreach programmes of Medicine Sans Frontieres. His medication comes in the form of generic drugs. However, this situation may not last long as economic interests of few may end up impeding many a public spirited...
More »SEARCH RESULT
Total Matching Records found : 382
It'll take more than markets to build a green future-Ashish Kothari
In August 2010, the U.N. Secretary General set up a “High-Level Panel on Global Sustainability,” to formulate a “new vision for sustainable growth and prosperity” for the world. Co-chaired by the Presidents of Finland and South Africa, the panel submitted its detailed report in January 2012. The report is under consideration in the Secretary General's office, and will be a key input to the upcoming U.N. Conference on Sustainable Development...
More »The Aamir Khan Column: Health care for the poor, a dream worth dreaming-Aamir Khan
What is the point of having a great GDP if as a society we are unhealthy? I am a bit of a dreamer. I dream that one day we will be living in a country where things will be different, and where the rich and the poor will both get the same, good, quality health care. To many it may seem like a totally impractical, and an unachievable dream. But it's...
More »Met predicts El Nino trouble for monsoon-Sanjeeb Mukherjee
The dreaded El Niño weather phenomenon is set to appear during the second half of the southwest monsoon, which may cause less-than-expected rains in August and September. El Niño had earlier hit the Indian monsoon in 2009, when the country faced a severe drought. This time, its impact is not clear as of now, but if there are excessive breaks in the monsoon, crops of paddy, oilseeds and pulses could...
More »Bayer demands withdrawal of Natco Pharma's compulsory licence-Khomba Singh
German drugmaker Bayer AG has demanded the withdrawal of the country's first compulsory licence given to Natco Pharma, arguing that a three-fourth reduction in the price of the anti-cancer drug by another Indian firm has made the permit redundant and its patent itself is vulnerable to being revoked. In March, India allowed Natco Pharma to legally make and sell a low-cost version of cancer drug Nexavar at 3% of the original...
More »
